New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
description
Transcript of New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
![Page 1: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/1.jpg)
New Users & Derivative ProductsTheme 3 for the Cochrane Strategic Discussion
Paris, April 2012
![Page 2: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/2.jpg)
Aim – Discuss ways to make Cochrane findings more accessible
• Help users find the Cochrane review they need• Build new derivative products using
components of reviews• Better integration between CDSR & CRS
![Page 3: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/3.jpg)
Should I take vitamins or supplements?
Can the Cochrane Library help me decide?
![Page 4: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/4.jpg)
![Page 5: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/5.jpg)
![Page 6: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/6.jpg)
Issues for the small groups
• How would you like to see Cochrane content displayed?
• What are the key components of Cochrane Reviews?– That should be displayed more frequently– Are likely to have the answers users are seeking– “Key” for other reasons
• What are the barriers or problems with these innovative displays?
![Page 7: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/7.jpg)
3 EXAMPLES TO GET YOU THINKING
![Page 8: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/8.jpg)
One Possible Approach
![Page 9: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/9.jpg)
![Page 10: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/10.jpg)
![Page 11: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/11.jpg)
![Page 12: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/12.jpg)
THE PICOTRON
Example #2
![Page 13: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/13.jpg)
• Cochrane Clinical Answers – succinct answers to specific clinical questions based on one or more Cochrane reviews
• The Problem – authors needed a lot of time to read the reviews & extract the succinct answers
• The Solution – The PICOtron – new software that can read & summarize Cochrane reviews
The Issues
![Page 14: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/14.jpg)
PICOtron Components
• Title• Abstract Conclusions• Methods – Types of
Participants, Interventions, Outcome Measures
• Results – Risk of Bias• Results – Data & Analyses• Figures – Forest Plots• Conclusions – Implications
for Practice
navigatingeffectivetreatments.org.au/
![Page 15: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/15.jpg)
LINKING TRIALS IN CENTRAL WITH COCHRANE REVIEWS
Example #3
http://rnd.wiley.com:8050/
![Page 17: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/17.jpg)
![Page 18: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/18.jpg)
![Page 19: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/19.jpg)
![Page 20: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/20.jpg)
![Page 21: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/21.jpg)
The Cochrane Collaboration could do more of this
• Structure of Cochrane content• Recent advances in technology
– No need for a long explanation, but here’s an idea of how it could work
– See recent talks by Chris Mavergames for more detail (links in the discussion forum)
![Page 22: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/22.jpg)
IMS data feed to Wiley
CDSR
CENTRAL
CENTRAL CRSArchie RevMan
Dow
nstr
eam
Ups
trea
m
Wiley Processing
Wiley Rendering
Our Current Process
![Page 23: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/23.jpg)
IMS data feed to Wiley
CDSR
CENTRAL
CENTRAL CRSArchie RevMan
Dow
nstr
eam
Ups
trea
m
Wiley Processing
Wiley Rendering
PICOtron
Author Summaries
![Page 24: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/24.jpg)
IMS data feed to Wiley
CDSR
CENTRAL
CENTRAL CRSArchie RevMan
Dow
nstr
eam
Ups
trea
m
Wiley Processing
Wiley Rendering
Demo of Trial/Review
Linkage
Wiley gears
![Page 25: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/25.jpg)
Flexible Delivery of Cochrane Content
Cochrane Library
(publisher)
Entity Web Sites
Cochrane.org Derivative Products
CENTRAL Data store CRS Archie RevMan
Linked data sets from
others
Dow
nstr
eam
Ups
trea
m
![Page 26: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/26.jpg)
First Small Group
• Start with an individual task– How would you like to see Cochrane content
displayed?– Draw a sketch to describe it
![Page 27: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/27.jpg)
![Page 28: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/28.jpg)
Sketching
• A conversation starter• Not a drawing• Neater isn’t better• Mistakes are encouraged • Might be all text
![Page 29: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/29.jpg)
Convene Small Group
• Present & Explain your sketch– Start the conversation
• What are the key components of Cochrane Reviews?– That should be displayed more frequently– Are likely to have the answers users are seeking– “Key” for other reasons
![Page 30: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/30.jpg)
Second Small Group
• Identifying Barriers or Issues• What will we need to address to make this
happen?
![Page 31: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/31.jpg)
![Page 32: New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012](https://reader035.fdocuments.in/reader035/viewer/2022081520/56816268550346895dd2d66d/html5/thumbnails/32.jpg)